CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: Study protocol for a randomised controlled trial

• Main Authors: Tong, S.Y.C, Nelson, J, Paterson, D.L, Fowler, V.G, Howden, B.P, Cheng, A.C, Chatfield, M, Lipman, J, Van Hal, S, O'Sullivan, M, Robinson, J.O, Yahav, D, Lye, D, Davis, J.S, CAMERA2 study group and the Australasian Society for Infectious Diseases Clinical Research Netwo
• Other Authors: MEDICINE
• Format: Article
• Published: 2020
• Subjects: cefazolin; cloxacillin; daptomycin; flucloxacillin; penicillin derivative; vancomycin; antiinfective agent; beta lactam; adult; antibiotic therapy; Article; Australia; bacterial load; blood culture; controlled study; drug cost; drug safety; health care availability; human; Israel; major clinical study; methicillin resistant Staphylococcus aureus infection; mortality; New Zealand; open study; parallel design; randomized controlled trial; relapse; Singapore; treatment duration; treatment failure; treatment outcome; clinical protocol; clinical trial; combination drug therapy; drug effects; isolation and purification; methicillin resistant Staphylococcus aureus; methodology; microbiology; multicenter study; pathogenicity; penicillin resistance; Staphylococcal Infections; time factor; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Research Design; Time Factors; Treatment Outcome; Vancomycin
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179951
• Institution: National University of Singapore

10.1186/S13063-016-1295-3